BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 36615841)

  • 1. Metabolic Homeostasis of Amino Acids and Diabetic Kidney Disease.
    Liu L; Xu J; Zhang Z; Ren D; Wu Y; Wang D; Zhang Y; Zhao S; Chen Q; Wang T
    Nutrients; 2022 Dec; 15(1):. PubMed ID: 36615841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological Targeting of Mitochondria in Diabetic Kidney Disease.
    Cleveland KH; Schnellmann RG
    Pharmacol Rev; 2023 Mar; 75(2):250-262. PubMed ID: 36781216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolomic profiling of amino acids study reveals a distinct diagnostic model for diabetic kidney disease.
    Wang J; Zhou C; Zhang Q; Liu Z
    Amino Acids; 2023 Nov; 55(11):1563-1572. PubMed ID: 37736814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetic Nephropathy: An Overview.
    Sagoo MK; Gnudi L
    Methods Mol Biol; 2020; 2067():3-7. PubMed ID: 31701441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of urinary acidification function with the progression of diabetic kidney disease in patients with type 2 diabetes.
    Zhu H; Liu X; Zhang C; Li Q; An X; Liu S; Wu L; Zhang B; Yuan Y; Xing C
    J Diabetes Complications; 2019 Nov; 33(11):107419. PubMed ID: 31473080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study of the natural history of diabetic kidney disease (DKD).
    Altemtam N; Russell J; El Nahas M
    Nephrol Dial Transplant; 2012 May; 27(5):1847-54. PubMed ID: 22058177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preventing the development and progression of diabetic kidney disease: Where do we stand?
    Zagkotsis G; Markou M; Paschou E; Papanikolaou P; Sabanis N
    Diabetes Metab Syndr; 2018 Jul; 12(4):585-590. PubMed ID: 29602760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on Pathogenesis of Glomerular Hyperfiltration in Early Diabetic Kidney Disease.
    Yang Y; Xu G
    Front Endocrinol (Lausanne); 2022; 13():872918. PubMed ID: 35663316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic imaging biomarkers for diabetic kidney disease (iBEAt): study protocol.
    Gooding KM; Lienczewski C; Papale M; Koivuviita N; Maziarz M; Dutius Andersson AM; Sharma K; Pontrelli P; Garcia Hernandez A; Bailey J; Tobin K; Saunavaara V; Zetterqvist A; Shelley D; Teh I; Ball C; Puppala S; Ibberson M; Karihaloo A; Metsärinne K; Banks RE; Gilmour PS; Mansfield M; Gilchrist M; de Zeeuw D; Heerspink HJL; Nuutila P; Kretzler M; Welberry Smith M; Gesualdo L; Andress D; Grenier N; Shore AC; Gomez MF; Sourbron S;
    BMC Nephrol; 2020 Jun; 21(1):242. PubMed ID: 32600374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical predictive factors in diabetic kidney disease progression.
    Radcliffe NJ; Seah JM; Clarke M; MacIsaac RJ; Jerums G; Ekinci EI
    J Diabetes Investig; 2017 Jan; 8(1):6-18. PubMed ID: 27181363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multidisciplinary management of diabetic kidney disease: a systematic review and meta-analysis.
    Helou N; Dwyer A; Shaha M; Zanchi A
    JBI Database System Rev Implement Rep; 2016 Jul; 14(7):169-207. PubMed ID: 27532796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetic kidney disease: new clinical and therapeutic issues. Joint position statement of the Italian Diabetes Society and the Italian Society of Nephrology on "The natural history of diabetic kidney disease and treatment of hyperglycemia in patients with type 2 diabetes and impaired renal function".
    Pugliese G; Penno G; Natali A; Barutta F; Di Paolo S; Reboldi G; Gesualdo L; De Nicola L;
    J Nephrol; 2020 Feb; 33(1):9-35. PubMed ID: 31576500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired Amino Acid Metabolism and Its Correlation with Diabetic Kidney Disease Progression in Type 2 Diabetes Mellitus.
    Zhu H; Bai M; Xie X; Wang J; Weng C; Dai H; Chen J; Han F; Lin W
    Nutrients; 2022 Aug; 14(16):. PubMed ID: 36014850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Glomerular Complement C4c Deposition With the Progression of Diabetic Kidney Disease in Patients With Type 2 Diabetes.
    Duan S; Sun L; Nie G; Chen J; Zhang C; Zhu H; Huang Z; Qian J; Zhao X; Xing C; Zhang B; Yuan Y
    Front Immunol; 2020; 11():2073. PubMed ID: 32983156
    [No Abstract]   [Full Text] [Related]  

  • 15. Anthocyanin improves kidney function in diabetic kidney disease by regulating amino acid metabolism.
    Li YX; Lu YP; Tang D; Hu B; Zhang ZY; Wu HW; Fan LJ; Cai KW; Tang C; Zhang YQ; Hong L; Dong JJ; Guan BZ; Yin LH; Dai Y; Bai WB; Zheng ZH; Zhu T
    J Transl Med; 2022 Nov; 20(1):510. PubMed ID: 36335368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum hemoglobin concentration and risk of renal function decline in early stages of diabetic kidney disease: a nationwide, biopsy-based cohort study.
    Yamanouchi M; Furuichi K; Shimizu M; Toyama T; Yamamura Y; Oshima M; Kitajima S; Hara A; Iwata Y; Sakai N; Oba Y; Matsuoka S; Ikuma D; Mizuno H; Suwabe T; Hoshino J; Sawa N; Yuzawa Y; Kitamura H; Suzuki Y; Sato H; Uesugi N; Ueda Y; Nishi S; Yokoyama H; Nishino T; Samejima K; Kohagura K; Shibagaki Y; Makino H; Matsuo S; Ubara Y; Wada T
    Nephrol Dial Transplant; 2022 Feb; 37(3):489-497. PubMed ID: 34028524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Artemether Alleviates Diabetic Kidney Disease by Modulating Amino Acid Metabolism.
    Rong G; Weng W; Huang J; Chen Y; Yu X; Yuan R; Gu X; Wu X; Cai Y; Han P; Shao M; Sun H; Ge N
    Biomed Res Int; 2022; 2022():7339611. PubMed ID: 35601149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and internal validation of machine learning algorithms for end-stage renal disease risk prediction model of people with type 2 diabetes mellitus and diabetic kidney disease.
    Zou Y; Zhao L; Zhang J; Wang Y; Wu Y; Ren H; Wang T; Zhang R; Wang J; Zhao Y; Qin C; Xu H; Li L; Chai Z; Cooper ME; Tong N; Liu F
    Ren Fail; 2022 Dec; 44(1):562-570. PubMed ID: 35373711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetic kidney disease: New clinical and therapeutic issues. Joint position statement of the Italian Diabetes Society and the Italian Society of Nephrology on "The natural history of diabetic kidney disease and treatment of hyperglycemia in patients with type 2 diabetes and impaired renal function".
    Pugliese G; Penno G; Natali A; Barutta F; Di Paolo S; Reboldi G; Gesualdo L; De Nicola L;
    Nutr Metab Cardiovasc Dis; 2019 Nov; 29(11):1127-1150. PubMed ID: 31586514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Markers of and risk factors for the development and progression of diabetic kidney disease.
    Macisaac RJ; Ekinci EI; Jerums G
    Am J Kidney Dis; 2014 Feb; 63(2 Suppl 2):S39-62. PubMed ID: 24461729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.